Enanta Pharmaceuticals
ENTA
#7987
Rank
ยฃ0.29 B
Marketcap
ยฃ10.23
Share price
0.36%
Change (1 day)
111.92%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2026 (TTM): ยฃ51.36 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ51.23 Million. In 2025 the company made a revenue of ยฃ49.73 Million a decrease over the revenue in the year 2024 that were of ยฃ53.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ51.36 M3.28%
2025 ยฃ49.73 M-6.27%
2024 ยฃ53.06 M-8.17%
2023 ยฃ57.78 M-14.84%
2022 ยฃ67.85 M-1.48%
2021 ยฃ68.88 M-7.63%
2020 ยฃ74.57 M-47.95%
2019 ยฃ0.14 B-23.71%
2018 ยฃ0.18 B94.5%
2017 ยฃ96.56 M137.16%
2016 ยฃ40.71 M-54.23%
2015 ยฃ88.95 M11.38%
2014 ยฃ79.86 M2489.78%
2013 ยฃ3.08 M-92.76%
2012 ยฃ42.58 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
ยฃ71.33 B 139,125.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ41.88 B 81,644.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ46.50 B 90,661.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ9.04 B 17,552.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.68 B 94,922.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ35.88 B 69,948.98%๐Ÿ‡บ๐Ÿ‡ธ USA